Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamio Teramoto

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 14, 2011
[Significance of clinical pathology in the field of internal medicine]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Leading role of Framingham Heart Study in the epidemiology on cardiovascular diseases]Tamio Teramoto
Atherosclerosis. Supplements|December 14, 2011
Pitavastatin: clinical effects from the LIVES StudyTamio Teramoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 4, 2004
[Clinical diagnosis of metabolic syndrome. 1. Significance and target in the treatment of hyperlipemia]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 28, 2002
[Revision of Japanese guideline for prevention of CHD based on recent evidences]Tamio Teramoto
Current Atherosclerosis Reports|August 7, 2002
Efficacy of raising high-density lipoprotein cholesterol for prevention of coronary heart diseaseTamio Teramoto
Circulation|May 9, 2018
Extending the "Lower is Better" Principle to Japanese and Possibly Other Asian PopulationsTamio Teramoto
Expert Opinion on Pharmacotherapy|February 16, 2012
The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-CTamio Teramoto
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 31, 2009
[Japan Atherosclerosis Society guidelines for prevention of atherosclerotic diseases in Japanese]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 28, 2007
[Role of HMG-CoA inhibitor (statin) in prevention of cerebral infarction]Tamio Teramoto
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 14, 2011
[Significance of clinical pathology in the field of internal medicine]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 27, 2007
[Leading role of Framingham Heart Study in the epidemiology on cardiovascular diseases]Tamio Teramoto
Atherosclerosis. Supplements|December 14, 2011
Pitavastatin: clinical effects from the LIVES StudyTamio Teramoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|June 4, 2004
[Clinical diagnosis of metabolic syndrome. 1. Significance and target in the treatment of hyperlipemia]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 28, 2002
[Revision of Japanese guideline for prevention of CHD based on recent evidences]Tamio Teramoto
Current Atherosclerosis Reports|August 7, 2002
Efficacy of raising high-density lipoprotein cholesterol for prevention of coronary heart diseaseTamio Teramoto
Circulation|May 9, 2018
Extending the "Lower is Better" Principle to Japanese and Possibly Other Asian PopulationsTamio Teramoto
Expert Opinion on Pharmacotherapy|February 16, 2012
The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-CTamio Teramoto
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 31, 2009
[Japan Atherosclerosis Society guidelines for prevention of atherosclerotic diseases in Japanese]Tamio Teramoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 28, 2007
[Role of HMG-CoA inhibitor (statin) in prevention of cerebral infarction]Tamio Teramoto
Pageof 19